Waldemar Kulikowski

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study

Claudio Agostinelli, Andrea Gallamini, Luisa Stracqualursi et al. · The Lancet Haematology · 2016 · 74 citations

Medicine, Oncology, Hematologic Oncology +16

Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study

C. Zwarthoed, Tarec Christoffer El‐Galaly, Maria Elisa Canepari et al. · Journal of Nuclear Medicine · 2017 · 35 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma

E. Bednaruk-Młyński, Joanna Pieńkowska, Adam Skórzak et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 34 citations

Medicine, Nuclear Medicine, Oncology +16

The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin’s lymphoma patients—the Polish Lymphoma Research Group (PLRG) Observational Study

Jan Maciej Zaucha, Bogdan Małkowski, Stéphane Chauvie et al. · Annals of Oncology · 2017 · 19 citations · Full text

Medicine, Oncology, Chemotherapy +11

Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma

Aleksandra G. Florek, Jan Maciej Zaucha, Ewa Chmielowska et al. · American Journal of Therapeutics · 2014 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +14